Value of a New QT Interval Correction Formula in Adjusting for Increases in Heart Rate

Journal Title: International Journal of Clinical Cardiology - Year 2017, Vol 4, Issue 3

Abstract

Background and objective QT interval correction for heart rate (QTc) is essential for clinical usage. A new QTc formula has been developed based on a data agnostic mathematical approach in a large population ECG data base. The formula requires testing on a within individual basis under conditions of intervention to increase heart rate. The objective of this study was to examine the stability and reliability the new QTc formulae within individuals when Heart Rate (HR) is increased by dobutamine. Methods HR and QT interval were measured in fifteen individuals who received intravenous dobutamine in a sequential protocol at 5, 10, 20, 30 and 40 micrograms/kg/min. Results Dobutamine produced a significant (p < 0.0001) increase in heart rate and a significant (p < 0.0001) reduction in QT. The new QTc formula showed relative stability with little change across the dobutamine dosages. Using a linear regression to evaluate the HR-QT interval, showed a significant (p < 0.0001) negative slope for the relationship. In contrast, the slope of the QTc-heart rate relationship for the new QTc formula did not differ from zero. Conclusion The new QT correction formula is relatively independent of the effect of increasing heart rate and should be useful QTc formula especially in conditions of increased heart rate.

Authors and Affiliations

Keywords

Related Articles

A Feasibility Pilot Study to Assess the Efficacy of NavX Guided Detection of Pulmonary Vein Electrograms during Atrial Fibrillation Ablation [NavX Guided Detection of Pulmonary Vein Electrograms]

Background Pulmonary Vein Antrum Isolation (PVAI) targeting PV triggers is an established treatment for paroxysmal Atrial Fibrillation (AF). Ablation lesions are typically delivered around the entire circumference of eac...

Pattern of Gender Variations in Acute Coronary Syndrome for Patients in Kuwait (Pagacks Study)

Introduction: Acute coronary syndrome (ACS) is a major cause of morbidity and mortality globally. The world has started laying emphasis on risk stratification based on gender differences. Hence, there seemed to be a void...

Pulmonary Artery Agenesis in Young Adult - Two Case Reports

A 21-year-old woman presented for a history of exertional dyspnoea and atypical chest pain. No history of allergies or tuberculosis. A chest X-ray showed asymmetry of the chest walls from a reduced expansion of the right...

Screening for Familial Hypercholesterolemia: West and North Zone in Manaus-Amazonas

Background: The Familial hypercholesterolemia (FH), is defined by LDL-c since 150 mg/ml (4.0 mmol/L) or more and Total Cholesterol 300 mg/ml or more, it is an inherited disease of two types, estimated frequency 1:400, fo...

Early Therapy with Beta Blockers Plus Ivabradine Versus Beta Blockers Alone in Patients Hospitalised with Heart Failure and Reduced Ejection Fraction (ETHIC-AHF Study): Results at One-Year Follow-Up

Heart rate (Hr) has prognostic value in patients with heart failure, depressed ejection fraction (HFrEF) and sinus rhythm. Objective: Is to analyze the effect of the early co-administration of ivabradine added to beta-b...

Download PDF file
  • EP ID EP352132
  • DOI 10.23937/2378-2951/1410101
  • Views 142
  • Downloads 0

How To Cite

(2017). Value of a New QT Interval Correction Formula in Adjusting for Increases in Heart Rate. International Journal of Clinical Cardiology, 4(3), 1-5. https://europub.co.uk/articles/-A-352132